Open Access

[Corrigendum] Kinesin family member 2A acts as a potential prognostic marker and treatment target via interaction with PI3K/AKT and RhoA/ROCK pathways in acute myeloid leukemia

  • Authors:
    • Xinglin Liang
    • Ruixiang Xia
  • View Affiliations

  • Published online on: December 13, 2022     https://doi.org/10.3892/or.2022.8463
  • Article Number: 26
  • Copyright : © Liang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

View Figures

Related Articles

Journal Cover

February-2023
Volume 49 Issue 2

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Liang X and Liang X: [Corrigendum] Kinesin family member 2A acts as a potential prognostic marker and treatment target via interaction with PI3K/AKT and RhoA/ROCK pathways in acute myeloid leukemia. Oncol Rep 49: 26, 2023
APA
Liang, X., & Liang, X. (2023). [Corrigendum] Kinesin family member 2A acts as a potential prognostic marker and treatment target via interaction with PI3K/AKT and RhoA/ROCK pathways in acute myeloid leukemia. Oncology Reports, 49, 26. https://doi.org/10.3892/or.2022.8463
MLA
Liang, X., Xia, R."[Corrigendum] Kinesin family member 2A acts as a potential prognostic marker and treatment target via interaction with PI3K/AKT and RhoA/ROCK pathways in acute myeloid leukemia". Oncology Reports 49.2 (2023): 26.
Chicago
Liang, X., Xia, R."[Corrigendum] Kinesin family member 2A acts as a potential prognostic marker and treatment target via interaction with PI3K/AKT and RhoA/ROCK pathways in acute myeloid leukemia". Oncology Reports 49, no. 2 (2023): 26. https://doi.org/10.3892/or.2022.8463